Roivant CAO granted RSUs and stock options
Roivant Sciences Ltd. reported a compensation-related equity grant to Chief Accounting Officer Jennifer Humes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Roivant Sciences Ltd. reported a compensation-related equity grant to Chief Accounting Officer Jennifer Humes. She received 29,173 Common Share RSUs, bringing her direct Common Share holdings to 113,364 shares after the award.
Humes was also granted 27,157 stock options to buy Common Shares at an exercise price of $29.08 per share, expiring on April 19, 2036. Both the RSUs and options have a vesting commencement date of April 20, 2026 and vest over time, subject to her continuous service with the company.
Insider Trade Summary
Grant/Award: 56,330 shares
Grant/Award
2 txns
Insider
Humes Jennifer
Role
Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 27,157 | $0.00 | $0.00 |
| Grant/Award | Common Shares | 29,173 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 27,157 contracts (Direct);
Common Shares — 113,364 shares (Direct)
Footnotes (2)
- F1. Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.
- F2. Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through each applicable vesting date.
Key Figures
RSUs granted: 29,173 Common Shares
Options granted: 27,157 options
Option exercise price: $29.08 per share
+3 more
6 metrics
RSUs granted
29,173 Common Shares
Restricted stock units awarded to CAO on April 20, 2026
Options granted
27,157 options
Stock options on Common Shares granted to CAO
Option exercise price
$29.08 per share
Exercise price for newly granted stock options
Shares held after grant
113,364 Common Shares
Direct Common Share holdings following RSU award
Option expiration date
April 19, 2036
Expiration of newly granted stock options
Vesting start date
April 20, 2026
Vesting commencement date for RSUs and options
Key Terms
restricted stock units, RSUs, stock options, vesting commencement date, +1 more
5 terms
restricted stock units financial
"Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter..."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
stock options financial
"Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2026."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vesting commencement date financial
"with a vesting commencement date of April 20, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Roivant Sciences (ROIV) grant to Jennifer Humes?
Roivant Sciences granted Chief Accounting Officer Jennifer Humes 29,173 RSUs and 27,157 stock options on Common Shares. These awards are part of her equity compensation and vest over time, subject to her continued service with the company.
What is the exercise price of Jennifer Humes’ new Roivant Sciences (ROIV) stock options?
The newly granted stock options to Jennifer Humes have an exercise price of $29.08 per Common Share. She can purchase shares at this fixed price once the options vest and before they expire, subject to the vesting schedule and her ongoing service.
When do Jennifer Humes’ RSUs from Roivant Sciences (ROIV) vest?
The RSUs granted to Jennifer Humes start vesting from a April 20, 2026 commencement date. 25% vest on the first anniversary, with the remaining RSUs vesting in twelve equal quarterly installments, assuming she remains in continuous service.
What is the vesting schedule for Jennifer Humes’ new Roivant Sciences (ROIV) stock options?
Her options begin vesting from a April 20, 2026 commencement date. 25% vest and become exercisable on the first anniversary, with the remaining options vesting in 36 equal monthly installments, contingent on her continuous service with Roivant.
When do Jennifer Humes’ Roivant Sciences (ROIV) stock options expire?
The stock options granted to Jennifer Humes expire on April 19, 2036. She may exercise vested options any time before this expiration date, subject to the plan terms and her ongoing service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates